摘要
肠道微生物通过多种机制与宿主生理相互作用,包括心血管(CV)系统。健康的微生物群有能力处理和消化复杂的碳水化合物为短链脂肪酸(SCFA)。这些短链脂肪酸具有信号分子、免疫调节分子和能量来源的功能。然而,当微生物群改变时,它会产生肠道生态失调,某些细菌的过度生长可能会导致磷脂酰胆碱、胆碱和肉碱代谢产生过多的三甲胺- n -氧化物(TMAO);生态失调还导致肠道通透性增加,允许微生物衍生的脂多糖(LPS),一种细菌内毒素进入血液循环,引发炎症反应。胃肠道(GI)环境的改变和微生物来源的代谢物与CV事件相关。微生物组的含量和功能紊乱导致TMAO和LPS水平升高、胆汁酸代谢途径改变和短链脂肪酸的产生与心血管疾病(CVD)的风险增加相关,包括动脉粥样硬化、心肌梗死、血栓形成、心律失常和中风。在某些情况下,治疗干预可能会有利地影响非生物胃肠道结构,并促进健康的微生物群,可能有利于CV系统,并导致心血管疾病发病率的降低。本文对这些问题进行了综述,重点是与微生物相关的心血管疾病的谱系、涉及的机制以及微生物组修饰作为一种可能的治疗干预的潜在用途。
关键词: 微生物组,微生物群,心血管疾病,代谢综合征,三甲胺- N -氧化物,人类胃肠道。
Current Medicinal Chemistry
Title:Gut Microbiota and Cardiovascular Disease: Symbiosis Versus Dysbiosis
Volume: 29 Issue: 23
关键词: 微生物组,微生物群,心血管疾病,代谢综合征,三甲胺- N -氧化物,人类胃肠道。
摘要: The gut microbiome interacts with host physiology through various mechanisms, including the cardiovascular (CV) system. A healthy microbiome has the ability to process and digest complex carbohydrates into short-chain fatty acids (SCFA). These SCFA function as signaling molecules, immune-modulating molecules, and energy sources. However, when the microbiome is altered, it produces gut dysbiosis with overgrowth of certain bacteria that may lead to overproduction of trimethylamine-N-oxide (TMAO) from the metabolism of phosphatidylcholine, choline, and carnitine; dysbiosis also leads to increased intestinal permeability allowing the microbiome-derived lipopolysaccharide (LPS), a bacterial endotoxin, to enter the blood circulation, triggering inflammatory responses. An altered gastrointestinal (GI) tract environment and microbiome- derived metabolites are associated with CV events. Disrupted content and function of the microbiome leading to elevated TMAO and LPS levels, altered bile acid metabolism pathways, and SCFA production are associated with an increased risk of CV diseases (CVD), including atherosclerosis, myocardial infarction, thrombosis, arrhythmias, and stroke. Therapeutic interventions that may favorably influence a dysbiotic GI tract profile and promote a healthy microbiome may benefit the CV system and lead to a reduction of CVD incidence in certain situations. These issues are herein reviewed with a focus on the spectrum of microbiota-related CVD, the mechanisms involved, and the potential use of microbiome modification as a possible therapeutic intervention.
Export Options
About this article
Cite this article as:
Gut Microbiota and Cardiovascular Disease: Symbiosis Versus Dysbiosis, Current Medicinal Chemistry 2022; 29 (23) . https://dx.doi.org/10.2174/0929867328666211213112949
DOI https://dx.doi.org/10.2174/0929867328666211213112949 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Seq and You Will Find
Current Gene Therapy Prospective Role of Polyphenolic Compounds in the Treatment of Neurodegenerative Diseases
CNS & Neurological Disorders - Drug Targets Role of NADPH Quinone Reductase 1 (NQO1) Polymorphism in Prevention, Diagnosis, and Treatment of Gastrointestinal Cancers
Current Cancer Drug Targets Evaluation of the Atherogenic Effect of Covid-19 Pneumonia on Coronary and Carotid Arteries in Patients who Recovered from the Disease
Current Medical Imaging <i>In Silico</i> Insight into the Inhibitory Effects of Active Antidiabetic Compounds from Medicinal Plants Against SARS-CoV-2 Replication and Posttranslational Modification
Coronaviruses Progenitor Cell Types in HIV-1 Infection: Bioactivity and Emerging Targets for Treatment
Current HIV Research Chemistry, Stability and Bioavailability of Resveratrol
Medicinal Chemistry Editorial [Hot Topic: Peripheral Proteins as Drug Targets (Guest Editor: Robert V. Stahelin) ]
Current Drug Targets Inflammation in Fish As Seen from A Morphological Point of View with Special Reference to the Vascular Compartment
Current Pharmaceutical Design Patent Selections
Recent Patents on Biomarkers Translational siRNA Therapeutics Using Liposomal Carriers: Prospects & Challenges
Current Gene Therapy The Management of the Infected Diabetic Foot
Current Diabetes Reviews Culture-Independent Bacterial Population Analysis – Clinical Implications for Respiratory and Other Infections
Current Respiratory Medicine Reviews Vitamin D and Asthma: Scientific Promise and Clinical Reality
Current Respiratory Medicine Reviews Design, Synthesis and In-vivo Hypoglycemic Evaluation of Novel Non - TZD’S in a Type - 2 Diabetic Model
Medicinal Chemistry Kinases as Drug Targets in Inflammation: In Vitro and In Vivo Target Validation and Expression Profiling
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Adipose-derived Stem Cells: Potentials, Availability and Market Size in Regenerative Medicine
Current Stem Cell Research & Therapy Synthesis and Biological Properties of Dihydro-Oxadiazine-Based Heterocyclic Derivatives
Mini-Reviews in Medicinal Chemistry An Update on Herbal Anti-inflammatory Agents in Periodontal Therapy
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued) Potential Role of Rho Kinase Inhibitors in Combating Diabetes-Related Complications Including Diabetic Neuropathy-A Review
Current Diabetes Reviews